About: pharma companies

Promoted content
Competition 10-07-2014

Commission fines pharmaceutical companies for drug-delay deals

The European Commission on Wednesday imposed fines totaling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines – Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin – for concluding a series of deals of deals all aimed at protecting Servier's bestselling blood pressure medicine, perindopril, from price competition by generics in the EU.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.